Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John J. Crowley Insider Profile
4 Followers
John J. Crowley, SVP & CAO at Charles River Labs, holds 4.93K shares in Charles River Labs (Ticker: CRL), holds ― shares in Fusion Pharmaceuticals (Ticker: FUSN).
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-6.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John J. Crowley holds in companies
Most Profitable Insider Trade
The most profitable trade made by John J. Crowley
John J. Crowley's Trading History
Charles River Labs
Oct 04, 2016
SVP & CAO
Uninformative Sell
23.67K
$1.14M
Fusion Pharmaceuticals
―
Chief Financial Officer
―
―
List of latest transactions for each holding click on a transaction to see John J. Crowley's performance on stock
You May Also Like
John J. Crowley insider profile FAQ
What is the percentage of profitable transactions made by John J. Crowley?
The percentage of profitable transactions made by John J. Crowley is 33%.
What is the average return per transaction made by John J. Crowley?
The average return per transaction made by John J. Crowley is -6.40%.
What stocks does John J. Crowley hold?
John J. Crowley holds: CRL, FUSN stocks.
What was John J. Crowley’s latest transaction?
John J. Crowley latest transaction was an Uninformative Sell of $23.67K.
What was John J. Crowley's most profitable transaction?
John J. Crowley’s most profitable transaction was an Informative Sell of CRL stock on March 5, 2015. The return on the trade was 4.10%.
What is John J. Crowley's role in Charles River Labs?
John J. Crowley's role in Charles River Labs is SVP & CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.